Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

608 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genomic landscape of cutaneous T cell lymphoma.
Choi J, Goh G, Walradt T, Hong BS, Bunick CG, Chen K, Bjornson RD, Maman Y, Wang T, Tordoff J, Carlson K, Overton JD, Liu KJ, Lewis JM, Devine L, Barbarotta L, Foss FM, Subtil A, Vonderheid EC, Edelson RL, Schatz DG, Boggon TJ, Girardi M, Lifton RP. Choi J, et al. Among authors: liu kj. Nat Genet. 2015 Sep;47(9):1011-9. doi: 10.1038/ng.3356. Epub 2015 Jul 20. Nat Genet. 2015. PMID: 26192916 Free PMC article.
Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models.
Tang YC, Ou JJ, Hsu SC, Huang CH, Lin LM, Chang HH, Wang YH, Huang ZT, Sun M, Liu KJ, Hung YM, Lai CY, Shih C, Chen CT, Chang JY, Hsieh HP, Jiaang WT, Kuo CC. Tang YC, et al. Among authors: liu kj. Pharmacol Res. 2025 Jan;211:107556. doi: 10.1016/j.phrs.2024.107556. Epub 2024 Dec 20. Pharmacol Res. 2025. PMID: 39709137 Free article.
Triple-targeted therapy of dabrafenib, trametinib, and osimertinib for the treatment of the acquired BRAF V600E mutation after progression on EGFR-tyrosine kinase inhibitors in advanced EGFR-mutated non-small cell lung cancer patients.
Weng CD, Liu KJ, Jin S, Su JW, Yao YH, Zhou CZ, Li YF, Chen ZX, Chen HJ, Li YY, Tang KJ, Yang JJ. Weng CD, et al. Among authors: liu kj. Transl Lung Cancer Res. 2024 Oct 31;13(10):2538-2548. doi: 10.21037/tlcr-24-358. Epub 2024 Oct 28. Transl Lung Cancer Res. 2024. PMID: 39507030 Free PMC article.
Association of CD19+-targeted chimeric antigen receptor (CAR) T-cell therapy with hypogammaglobulinemia, infection, and mortality.
Sutherland NM, Zhou B, Zhang L, Ong MS, Hong JS, Pak A, Liu KJ, Frigault MJ, Maus MV, Hill JA, Reynolds K, Walter JE, Camargo CA Jr, Barmettler S. Sutherland NM, et al. Among authors: liu kj. J Allergy Clin Immunol. 2024 Nov 4:S0091-6749(24)01165-5. doi: 10.1016/j.jaci.2024.10.021. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39505278
608 results